Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Mosor, Maria ^a   Ziółkowska Suchanek, Iwona ^a   Nowicka, Karina ^a   Dzikiewicz Krawczyk, Agnieszka ^a   Januszkiewicz Lewandowska, Danuta ^a,b   Nowak, Jerzy ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MRE11 PROTEIN; RAD50 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; COMPLEX FORMATION; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MRE11 GENE; NBN GENE; ONSET AGE; RAD50 GENE; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ALLELES; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; GENE FREQUENCY; GENOMIC INSTABILITY; GENOTYPE; GERM-LINE MUTATION; HUMANS; INFANT; LEUKEMIA; MULTIPROTEIN COMPLEXES; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84884966585     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-457     Document Type: Article

References (38)

1. Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JW. Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer 2006, 42(13):2183-2190. 10.1016/j.ejca.2006.06.006, 16919780.
2. Assenmacher N, Hopfner KP. MRE11/RAD50/NBS1: complex activities. Chromosoma 2004, 113(4):157-166.
3. Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH, Taylor AM. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 1999, 99(6):577-587. 10.1016/S0092-8674(00)81547-0, 10612394.
4. Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, Wieland B, Varon R, Lerenthal Y, Lavin MF, et al. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am J Hum Genet 2009, 84(5):605-616. 10.1016/j.ajhg.2009.04.010, 2681000, 19409520.
5. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998, 93(3):467-476. 10.1016/S0092-8674(00)81174-5, 9590180.
6. Mosor M, Ziolkowska I, Pernak-Schwarz M, Januszkiewicz-Lewandowska D, Nowak J. Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia 2006, 20(8):1454-1456. 10.1038/sj.leu.2404285, 16810201.
7. Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, Pernak M, Litwiniuk M, Nowak J. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res Treat 2008, 110(2):343-348. 10.1007/s10549-007-9734-1, 17899368.
8. Ziolkowska I, Mosor M, Wierzbicka M, Rydzanicz M, Pernak-Schwarz M, Nowak J. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci 2007, 98(11):1701-1705. 10.1111/j.1349-7006.2007.00594.x, 17894553.
9. Nowak J, Mosor M, Ziolkowska I, Wierzbicka M, Pernak-Schwarz M, Przyborska M, Roznowski K, Plawski A, Slomski R, Januszkiewicz D. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur J Cancer 2008, 44(4):627-630. 10.1016/j.ejca.2008.01.006, 18280732.
10. Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, Nowakowska D, Rubach M, Kosakowska E, Ruka W, et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. International journal of cancer Journal international du cancer 2004, 111(1):67-71. 10.1002/ijc.20239, 15185344.
11. Cybulski C, Gorski B, Debniak T, Gliniewicz B, Mierzejewski M, Masojc B, Jakubowska A, Matyjasik J, Zlowocka E, Sikorski A, et al. NBS1 is a prostate cancer susceptibility gene. Cancer Res 2004, 64(4):1215-1219. 10.1158/0008-5472.CAN-03-2502, 14973119.
12. Lu M, Lu J, Yang X, Yang M, Tan H, Yun B, Shi L. Association between the NBS1 E185Q polymorphism and cancer risk: a meta-analysis. BMC cancer 2009, 9:124. 10.1186/1471-2407-9-124, 2680905, 19393077.
13. Mosor M, Ziolkowska I, Januszkiewicz-Lewandowska D, Nowak J. Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia. Eur J Cancer 2008, 44(15):2226-2232. 10.1016/j.ejca.2008.06.026, 18691878.
14. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, Lundan T, Mannermaa A, Borresen-Dale AL, Borg A, Barkardottir RB, et al. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 2006, 27(8):1593-1599. 3006189, 16474176.
15. Tommiska J, Seal S, Renwick A, Barfoot R, Baskcomb L, Jayatilake H, Bartkova J, Tallila J, Kaare M, Tamminen A, et al. Evaluation of RAD50 in familial breast cancer predisposition. International journal of cancer Journal international du cancer 2006, 118(11):2911-2916. 10.1002/ijc.21738, 16385572.
16. Mosor M, Ziolkowska-Suchanek I, Roznowski K, Baranowska M, Januszkiewicz-Lewandowska D, Nowak J. RAD50 gene mutations are not likely a risk factor for breast cancer in Poland. Breast Cancer Res Treat 2010, 123(2):607-609. 10.1007/s10549-010-0992-y, 20571869.
17. Fukuda T, Sumiyoshi T, Takahashi M, Kataoka T, Asahara T, Inui H, Watatani M, Yasutomi M, Kamada N, Miyagawa K. Alterations of the double-strand break repair gene MRE11 in cancer. Cancer Res 2001, 61(1):23-26.
18. Heikkinen K, Karppinen SM, Soini Y, Makinen M, Winqvist R. Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility. J Med Genet 2003, 40(12):e131. 10.1136/jmg.40.12.e131, 1735331, 14684699.
19. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314(5797):268-274. 10.1126/science.1133427, 16959974.
20. Sun C, Southard C, Witonsky DB, Olopade OI, Di Rienzo A. Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15. Hum Mutat 2010, 31(1):99-107. 10.1002/humu.21145, 2922057, 19847790.
21. Bray NJ, O'Donovan MC. Investigating cis-acting regulatory variation using assays of relative allelic expression. Psychiatr Genet 2006, 16(4):173-177. 10.1097/01.ypg.0000218612.35139.84, 16829785.
22. Muller D, Rouleau E, Schultz I, Caputo S, Lefol C, Bieche I, Caron O, Nogues C, Limacher JM, Demange L, et al. An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition. BMC Med Genet 2011, 12:121. 10.1186/1471-2350-12-121, 3198910, 21939546.
23. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010, 26(16):2069-2070. 10.1093/bioinformatics/btq330, 2916720, 20562413.
24. Rosenbloom KR, Dreszer TR, Long JC, Malladi VS, Sloan CA, Raney BJ, Cline MS, Karolchik D, Barber GP, Clawson H, et al. ENCODE whole-genome data in the UCSC Genome Browser: update 2012. Nucleic Acids Res 2012, 40(Database issue):D912-D917. 3245183, 22075998.
25. Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, Kirkup VM, Wong MC, Maddren M, Fang R, Heitner SG, et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res 2013, 41(Database issue):D56-D63. 3531152, 23193274.
26. Bartkova J, Tommiska J, Oplustilova L, Aaltonen K, Tamminen A, Heikkinen T, Mistrik M, Aittomaki K, Blomqvist C, Heikkila P. Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene. Mol Oncol 2008, 2(4):296-316. 10.1016/j.molonc.2008.09.007, 19383352.
27. Fernet M, Gribaa M, Salih MA, Seidahmed MZ, Hall J, Koenig M. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet 2005, 14(2):307-318.
28. Giannini G, Ristori E, Cerignoli F, Rinaldi C, Zani M, Viel A, Ottini L, Crescenzi M, Martinotti S, Bignami M, et al. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 2002, 3(3):248-254. 10.1093/embo-reports/kvf044, 1084012, 11850399.
29. Park YB, Chae J, Kim YC, Cho Y. Crystal structure of human Mre11: understanding tumorigenic mutations. Structure 2011, 19(11):1591-1602. 10.1016/j.str.2011.09.010, 22078559.
30. Onnie C, Fisher SA, King K, Mirza M, Roberts R, Forbes A, Sanderson J, Lewis CM, Mathew CG. Sequence variation, linkage disequilibrium and association with Crohn's disease on chromosome 5q31. Genes Immun 2006, 7(5):359-365. 10.1038/sj.gene.6364307, 16724073.
31. Walter MJ, Payton JE, Ries RE, Shannon WD, Deshmukh H, Zhao Y, Baty J, Heath S, Westervelt P, Watson MA, et al. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci USA 2009, 106(31):12950-12955. 10.1073/pnas.0903091106, 2716381, 19651600.
32. Uhrhammer N, Delort L, Bignon YJ. Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population. Cancer Epidemiol Biomarkers Prev 2009, 18(2):684-685. 10.1158/1055-9965.EPI-08-0971, 19190165.
33. Cao AY, Hu Z, Yin WJ, Jin W, Shao ZM. Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer. Breast Cancer Res Treat 2010, 121(1):247-249. 10.1007/s10549-009-0629-1, 19904603.
34. Ciara E, Piekutowska-Abramczuk D, Popowska E, Grajkowska W, Barszcz S, Perek D, Dembowska-Baginska B, Perek-Polnik M, Kowalewska E, Czajnska A, et al. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients. Acta Neuropathol 2010, 119(3):325-334. 10.1007/s00401-009-0608-y, 19908051.
35. Nowak J, Mosor M, Nowicka K, Rembowska J, Januszkiewicz D. Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in children?. J Pediatr Hematol Oncol 2011, 33(6):e248-e249. 10.1097/MPH.0b013e3181faf886, 21436738.
36. Dzikiewicz-Krawczyk A, Mosor M, Januszkiewicz D, Nowak J. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions. Mutagenesis 2012, 27(3):337-343. 10.1093/mutage/ger084, 22131123.
37. Jiang L, Liang J, Jiang M, Yu X, Zheng J, Liu H, Wu D, Zhou Y. Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese population. Eur J Haematol 2011, 86(3):199-205. 10.1111/j.1600-0609.2010.01562.x, 21166880.
38. Yao F, Fang Y, Chen B, Jin F, Wang S. Association between the NBS1 Glu185Gln polymorphism and breast cancer risk: a meta-analysis. Tumour Biol 2013, 34(2):1255-1262. 10.1007/s13277-013-0668-4, 23381647.